Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
TechCrunch AI ·
Summary
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
- Source
- TechCrunch AI
- Published (IST)
Original reporting belongs to TechCrunch AI. DEEKOYA links the headline and a short excerpt only; we do not republish the full article.
Explore more: Today in AI · Research papers · AI tools · Learn AI
Related stories
The Guardian AI
US senators urge White House AI chief to fix vulnerabilities after mass outages
As Democrats flag AI bank breaches and cyberattacks in Japan, Jay Clayton says system failures happen US politics live…
The Guardian AIAI
- TechTarget
Microsoft unveils Copilotforce, expands Office inside Copilot
TechTargetAI
- Healthcare Dive
AI is coming for primary care
Healthcare DiveAI
- The South First
Bengaluru consolidates position as India’s AI capital, dominates funding
The South FirstFunding
Unite.AI
Gallium Studios Taps Artificial Agency for Will Wright’s MyMems
Artificial Agency announced on November 18, 2026 that Gallium Studios, the game studio founded by Will Wright, had…
Unite.AIAI
Unite.AI
Payhawk Raises $280M Series C at $2B Valuation to Build an AI Finance OS
Payhawk announced a $280 million all-equity Series C on November 18, 2026, led by Growth Equity at Goldman Sachs…
Unite.AIFunding
Who reported “Isomorphic Labs raises $5B as it looks to take drug candidates to clinical…”?
TechCrunch AI, on 17 Nov 2026. The full article is at the source link on this page.
Comments
No comments yet. Share your own experience below.
Visitor posts are moderated before they appear and are the opinion of their authors, not DEEKOYA AI. Names are not verified. See our privacy policy.